Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patellar Ligament | 1 | 2024 | 15 | 0.960 |
Why?
|
| Tibial Fractures | 1 | 2024 | 68 | 0.910 |
Why?
|
| Osteoporosis | 1 | 2022 | 232 | 0.690 |
Why?
|
| Psoas Muscles | 1 | 2019 | 12 | 0.650 |
Why?
|
| Bone Density | 1 | 2022 | 466 | 0.650 |
Why?
|
| Pelvic Bones | 1 | 2019 | 102 | 0.610 |
Why?
|
| Sarcopenia | 1 | 2019 | 114 | 0.570 |
Why?
|
| Fractures, Bone | 1 | 2019 | 310 | 0.520 |
Why?
|
| Tendon Injuries | 1 | 2024 | 26 | 0.240 |
Why?
|
| Rotation | 1 | 2024 | 97 | 0.240 |
Why?
|
| Benzodioxoles | 2 | 2012 | 29 | 0.190 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 235 | 0.190 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 247 | 0.180 |
Why?
|
| Radiography | 1 | 2024 | 1986 | 0.170 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 745 | 0.160 |
Why?
|
| Blood-Brain Barrier | 2 | 2009 | 251 | 0.150 |
Why?
|
| Quinazolines | 2 | 2012 | 956 | 0.130 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 6177 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2024 | 39890 | 0.120 |
Why?
|
| Risk Factors | 2 | 2024 | 17888 | 0.120 |
Why?
|
| Sex Factors | 1 | 2019 | 2184 | 0.110 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 104 | 0.100 |
Why?
|
| Colorectal Neoplasms | 3 | 2012 | 3707 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 339 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 217 | 0.090 |
Why?
|
| Hospitalization | 1 | 2019 | 2167 | 0.080 |
Why?
|
| Camptothecin | 1 | 2012 | 540 | 0.080 |
Why?
|
| CD59 Antigens | 1 | 2009 | 11 | 0.080 |
Why?
|
| Age Factors | 1 | 2019 | 5457 | 0.080 |
Why?
|
| Pituitary Diseases | 1 | 2009 | 19 | 0.080 |
Why?
|
| Complement C5a | 1 | 2009 | 35 | 0.080 |
Why?
|
| Brain Edema | 1 | 2009 | 95 | 0.080 |
Why?
|
| Burns | 1 | 2009 | 130 | 0.080 |
Why?
|
| Male | 4 | 2024 | 128315 | 0.080 |
Why?
|
| Encephalitis | 1 | 2009 | 153 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2012 | 5408 | 0.070 |
Why?
|
| Female | 4 | 2024 | 148940 | 0.070 |
Why?
|
| Child | 2 | 2024 | 30559 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 7783 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1710 | 0.060 |
Why?
|
| Survival Rate | 1 | 2019 | 12541 | 0.060 |
Why?
|
| Humans | 8 | 2024 | 270740 | 0.060 |
Why?
|
| Adolescent | 1 | 2024 | 32767 | 0.060 |
Why?
|
| Sepsis | 1 | 2009 | 686 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2009 | 776 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2012 | 895 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 425 | 0.040 |
Why?
|
| Gene Dosage | 2 | 2012 | 823 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 30998 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2012 | 3917 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2012 | 2313 | 0.030 |
Why?
|
| Brain | 1 | 2009 | 4208 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 2471 | 0.030 |
Why?
|
| Pediatrics | 1 | 2024 | 1186 | 0.030 |
Why?
|
| Aged | 1 | 2019 | 73333 | 0.030 |
Why?
|
| Mutation | 1 | 2012 | 15912 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2012 | 101 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 589 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 529 | 0.020 |
Why?
|
| Mice | 4 | 2012 | 35600 | 0.020 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2009 | 13 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2012 | 487 | 0.020 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2009 | 8 | 0.020 |
Why?
|
| Animals | 5 | 2012 | 61956 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2009 | 81 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2009 | 88 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 609 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2009 | 153 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2009 | 374 | 0.020 |
Why?
|
| fas Receptor | 1 | 2009 | 197 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 14617 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 1012 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 14849 | 0.020 |
Why?
|
| Apoptosis | 2 | 2010 | 7757 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 1129 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 4329 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2012 | 12103 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 2156 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2010 | 3045 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1542 | 0.010 |
Why?
|
| Biomarkers, Tumor | 2 | 2012 | 10708 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 5149 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 6441 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 7655 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 5728 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2012 | 2887 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 6390 | 0.010 |
Why?
|
| Neurons | 1 | 2009 | 2439 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 5051 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 7238 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 7100 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 7381 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 4961 | 0.010 |
Why?
|